Audinate Ltd flags more "strong growth" in next 12 months

Audinate Ltd (ASX:AD8) is widely tipped by small cap investors as having a bright future.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This morning professional audio system business Audinate Ltd (ASX: AD8) reported a statutory net profit of $2.5 million on revenue of $19.7 million for the half year ending June 30, 2018. The profit result was a huge improvement on the $20.4 million loss in the prior year, with revenue also up 30%, or 35% in constant currency US dollar terms.

It should be noted that the big swing from loss to profit is due to a one-off non-cash charge incurred in FY 2017 that was related to a "change in fair value of convertible preference shares" over the 2017 financial year. The FY 2018 profit result also benefited from a $2.4 million one-off tax related gain as a result of Audinate entering a new "tax consolidated group in Australia".

The group beat its IPO prospectus forecasts with positive EBITDA (operating income) of $0.6 million, with gross margins flat at an albeit impressive 75%.

On an operational basis the group reported that: "Dante enabled original equipment manufacturers (OEMs) products available for sale increased to 1,639 products at 30 June 2018, up 39% from 1,182 at 30 June, 2017. Sales of modules, chips and cards shipped in FY18 was (sic) up 38% to approximately 238,000 units. The Group continues to grow the number of OEMs adopting Dante to 438 manufacturer brands as at 30 June 2018, up from 369 at 30 June 2017".

Management flagged that this remains a growth business with planned investments in sales and marketing resources over FY 2019, while investing in the tech development behind current and new products.

As a result revenue growth is expected to be in a range consistent with historic performance, although it seems the company declined to provide a forecast for earnings given the plans for rising investments.

However, the CEO noted he believes the group has "strong growth prospects" over the next 12 months.

The stock closed flat at $3.89.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »